Following the CDC announcement that FDA emergency use authorization (EUA) for its COVID-19 PCR test will be withdrawn at the end of 2021, GlobalData, a data and analytics company, offers an analyst's view from Dara Lo, Medical Devices Analyst at GlobalData.

July 27, 2021 — Following the CDC announcement that FDA emergency use authorization (EUA) for its COVID-19 PCR test will be withdrawn at the end of 2021, GlobalData, a data and analytics company, offers an analyst's view from Dara Lo, Medical Devices Analyst at GlobalData.

“This planned withdrawal could mark a bellwether of EUA approved COVID-19 tests coming to an end. This would have a huge impact on the entire COVID-19 testing industry in the U.S., which is currently comprised almost entirely of COVID-19 tests with only FDA EUA approval. In contrast to fully FDA approved medical tests, EUAs are only given during a declared emergency; outside of this, an EUA cannot be given and cannot be used.

“With the significant decline in COVID-19 testing in the US reported in the first half of the year, and the wide availability of COVID-19 vaccines, this state of emergency cannot last forever. Yet, COVID-19 testing will remain paramount in the monitoring of the prevalence of COVID-19, as well as vaccine efficacy. So even when the pandemic passes, COVID-19 tests will still be needed, similar to how influenza testing is regularly used.

“If and when FDA EUA comes to an end, manufacturers of COVID-19 tests will need to seek regular FDA approval, which can require even more clinical evidence than what was required for an EUA.”

For more information: www.globaldata.com

For the latest information on COVID-19 and the medical imaging industry, see ITN's COVID-19 channel

 

Related Radiology COVID-19 Content:

Medical AI Models Rely on 'Shortcuts' That Could Lead to Misdiagnosis of COVID-19

CT Provides Best Diagnosis for Novel Coronavirus (COVID-19)

SNMMI Image of the Year: PET Imaging Measures Cognitive Impairment in COVID-19 Patients

Cardiac MRI Effective in Detecting Asymptomatic, Symptomatic Myocarditis in Athletes

PHOTO GALLERY: How COVID-19 Appears on Medical Imaging

VIDEO: How to Image COVID-19 and Radiological Presentations of the Virus — Interview with Margarita Revzin, M.D.

How Does COVID-19 Appear in the Lungs?

Find more radiology related COVID news and video

PHOTO GALLERY: How COVID-19 Appears on Medical Imaging

 


Related Content

News | X-Ray

April 14, 2026 — KA Imaging is seeing continued adoption of its X-ray technology across new regions, with recent ...

Time April 15, 2026
arrow
News | Ultrasound Imaging

April 9, 2026 — GE HealthCare has announced a digital integration between the GE HealthCare bkActiv intraoperative ...

Time April 09, 2026
arrow
News | Radiology Imaging

April 7, 2026 — Onvida Health and Siemens Healthineers have entered a 10-year Value Partnership¹ designed to bring the ...

Time April 09, 2026
arrow
News | Teleradiology

April 1, 2026 — Premier Radiology Services has acquired Global Imaging Solutions (GLOBIS), a leading teleradiology group ...

Time April 03, 2026
arrow
News | Digital Pathology

March 29, 2026 — Leica Microsystems has introduced the Viventis SCAPE light sheet microscope. Viventis SCAPE enables ...

Time April 01, 2026
arrow
News | Radiology Business

March 31, 2026 — Radon Medical Imaging, a medical imaging equipment maintenance and repair services company, has has ...

Time March 31, 2026
arrow
News | Radiology Imaging

March 26, 2026 — GE HealthCare has announced a renewed research collaboration with Stanford Medicine Department of ...

Time March 30, 2026
arrow
News | Cardiac Imaging

March 28, 2026 — When Ashley Perlow felt a sharp pain shoot across her chest and into both wrists, she didn't think it ...

Time March 30, 2026
arrow
News | Digital Pathology

March 11, 2026 — Royal Philips has announced the expansion of its digital pathology portfolio with new cloud-enabled ...

Time March 26, 2026
arrow
News | FDA

March 24, 2026 — MARS Bioimaging, a New Zealand–headquartered medical device company, has received U.S. Food and Drug ...

Time March 25, 2026
arrow
Subscribe Now